Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,930
Closed -$201K 386
2024
Q4
$201K Buy
+3,930
New +$204K 0.03% 338
2024
Q3
Sell
-124,827
Closed -$5.02M 364
2024
Q2
$5.02M Sell
124,827
-32,420
-21% -$1.23M 0.69% 40
2024
Q1
$6.3M Sell
157,247
-8,505
-5% -$320K 0.86% 30
2023
Q4
$6.24M Buy
165,752
+4,900
+3% +$150K 0.88% 32
2023
Q3
$4.47M Sell
160,852
-39,860
-20% -$1.25M 0.71% 41
2023
Q2
$6.07M Buy
200,712
+55,688
+38% +$1.63M 0.67% 27
2023
Q1
$4.47M Buy
+145,024
New +$5.52M 0.6% 47
2022
Q2
Sell
-10,670
Closed -$523K 347
2022
Q1
$523K Buy
10,670
+6,340
+146% +$321K 0.07% 216
2021
Q4
$207K Buy
+4,330
New +$205K 0.03% 312

Other funds holding SNV

Pekin Hardy Strauss's SNV Position: Q1 2025 in Review

Pekin Hardy Strauss sold out of Synovus (SNV) in Q1 2025, closing a stake of 3,930 shares — an estimated $201K sold.

Pekin Hardy Strauss first reported a position in SNV in Q4 2021 and held it in 9 quarters. The position peaked at $6.3M in Q1 2024. 478 funds tracked by Wall St. Rank hold SNV as of Q1 2025.

  • Pekin Hardy Strauss reported no remaining Synovus position as of Q1 2025 after selling out during the quarter.
  • Pekin Hardy Strauss sold 3,930 Synovus shares in Q1 2025, an estimated $201K.
  • Pekin Hardy Strauss first reported a position in Synovus in Q4 2021 and held it in 9 quarters.
  • Pekin Hardy Strauss's Synovus position peaked at $6.3M in Q1 2024.
  • 478 funds tracked by Wall St. Rank held Synovus as of Q1 2025.

Based on Pekin Hardy Strauss's 13F filing for Q1 2025, filed 30 Apr 2025.